Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Mayo Yoshimi

Department of Hematology and Immunology, Kagoshima University Hospital, Kagoshima, Japan
Publications

Adult T cell Leukemia and Lymphoma Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant Risk Evaluation

Disease status at allogeneic hematopoietic cell transplantation (HCT) is an important pretransplant prognostic factor of HCT in adult T cell leukemia/ carcinoma (ATL); still, other prognostic factors, including comorbidities, weren't prophetic in small cohort analyses. Several scoring systems (HCT-specific comorbidity indicator (HCT- CI)/ modified ... Read More»

Mayo Yoshimi

: Transplant Rep 2023, 8: 166

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top